Overview

Use of N-Acetylcysteine During Liver Procurement

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Randomized prospective study on the impact on the post-LT outcome by the infusion of N-acetylcysteine (NAC) during the liver procurement procedure, as an anti-oxidant agent to reduce the ischemia-reperfusion damage of organs for liver transplantation (LT).
Phase:
Phase 2
Details
Lead Sponsor:
Azienda Ospedaliera di Padova
Treatments:
Acetylcysteine